Top Markets
#1 Official Trump Official Trump +41.49%
#2 Melania Meme Melania Meme +24.96%
#3 Nockchain Nockchain +24.66%
#4 Wrapped STX (Velar) Wrapped STX (Velar) +21.17%
#5 Mubarak Mubarak +19.32%
#6 EXOD EXOD +18.93%
#7 Unit Pump Unit Pump +16.04%
#8 Pump.fun Pump.fun +16.04%
#9 MowCat MowCat +14.02%
#10 Wrapped POL Wrapped POL +13.94%
Coin of the day
Official Trump Official Trump
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
MaaT Pharma S.A. MaaT Pharma S.A.

MaaT Pharma S.A.

MAAT
Classifica tra le azioni #23616
MaaT Pharma SA operates as a clinical-stage biotechnology company, focused on... MaaT Pharma SA operates as a clinical-stage biotechnology company, focused on the discovery and advancement of microbiome-based biotherapies, primarily for the treatment of solid cancer tumors. Its development pipeline features MaaT013, which has successfully completed Phase 2 clinical trials for acute graft-versus-host disease (aGVHD) and is also undergoing preclinical evaluation for melanoma. Another therapeutic candidate, MaaT033, is currently in Phase 1b clinical trials, aiming to improve survival outcomes for patients with acute myeloid leukemia (AML) or other liquid malignancies following allogeneic hematopoietic stem cell transplantation. Furthermore, MaaT03X is being developed specifically for solid tumor applications. The company was founded in 2014 and maintains its headquarters in Lyon, France.
Prezzo delle azioni
$3.78
Ultima sincronizzazione: 2026-08-21
Capitalizzazione di mercato
$71.20M
Variazione (1 giorno)
2.24%
Variazione (1 anno)
-43.37%
Paese
FR
Scambia MaaT Pharma S.A. (MAAT)

Categoria

Healthcare
Ricavi di MaaT Pharma S.A. (MAAT)
Ricavi nel Aug 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di MaaT Pharma S.A., i ricavi attuali dell'azienda (TTM) sono pari a 0. Nel 2026, l'azienda ha registrato ricavi di 0 uguale a i ricavi dell'anno 2026, che erano pari a 0. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per MaaT Pharma S.A. da 2026 a 2026
Ricavi alla fine di ogni anno
Anno Ricavi Cambia
Non abbastanza dati per le date fornite.
Ricavi di aziende simili o concorrenti
Azienda Ricavi Differenza nei ricavi Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH